Eton Pharmaceuticals ETON
NASDAQ ETON
$58.83 -0.51 (-0.87%)
At close: Sep 9, 2026 · 4:00 PM EDT

Eton Pharmaceuticals (ETON) Preferred Dividend Payments (2018)

Eton Pharmaceuticals' (ETON) quarterly Preferred Dividend Payments came in at $22.3 million in Q4 2018, up 2963.37% quarter-over-quarter from $729000.0 in Q3 2018.

Analysis

Eton Pharmaceuticals (ETON) Preferred Dividend Payments (2018) Analysis & Trends

Eton Pharmaceuticals has disclosed Preferred Dividend Payments across 1 years of filings, most recently posting $22.3 million for Q4 2018.

  • In Q4 2018, Preferred Dividend Payments changed N/A year-over-year to $22.3 million; the TTM figure through Dec 2018 stood at $24.5 million (changed N/A YoY), while the FY2018 annual figure was $24.5 million, up 1551.31% from the prior year.
  • Preferred Dividend Payments came in at $22.3 million for Q4 2018 at Eton Pharmaceuticals, up from $729000.0 in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $22.3 million in Q4 2018 to a low of $706000.0 in Q1 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn -
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn -
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn -
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn -
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn -
7 Revolution Medicines 43.79 Bn 43.79 Bn - -
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn -
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn -
10 Eton Pharmaceuticals 1.63 Bn 1.60 Bn 25.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 22.33 Mn
Sep 30, 2018 729,000.00
Jun 30, 2018 722,000.00
Mar 31, 2018 706,000.00